Testing effectiveness (Phase 2)WithdrawnNCT05176288What this trial is testingAvelumab, Palbociclib and Axitinib in Advanced RCCWho this might be right forAdvanced Clear Cell Renal Cell Carcinoma Bradley A. McGregor, MD
Testing effectiveness (Phase 2)Looking for participantsNCT05665361What this trial is testingPalbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)Who this might be right forAdvanced Clear Cell Renal Carcinoma (Ccrcc)Papillary Renal Cell Carcinoma (Prcc) National Cancer Institute (NCI) 100
Early research (Phase 1)Looking for participantsNCT07195916What this trial is testingEvaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesWho this might be right forSolid TumorsHematologic Malignancies Incyte Corporation 280
Early research (Phase 1)Ended earlyNCT02543645What this trial is testingVarlilumab and Atezolizumab in Patients With Advanced CancerWho this might be right forCarcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more Celldex Therapeutics 18
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT07123090What this trial is testingSasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell CarcinomaMetastatic Renal CancerRenal Cell Carcinoma+3 more Stephanie Berg 25
Testing effectiveness (Phase 2)Looking for participantsNCT06940518What this trial is testingPhase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forIvonescimabClear Cell Renal Carcinoma M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT03075423What this trial is testingRandomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCCWho this might be right forMetastatic Renal Cell Carcinoma Goethe University 316
Testing effectiveness (Phase 2)UnknownNCT00293501What this trial is testingTinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By SurgeryWho this might be right forKidney Cancer University of Vermont 35
Testing effectiveness (Phase 2)Study completedNCT04704219What this trial is testingPembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 160
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706What this trial is testingPembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)Who this might be right forCarcinoma, Renal Cell Merck Sharp & Dohme LLC 1,854
Testing effectiveness (Phase 2)UnknownNCT03475953What this trial is testingA Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsWho this might be right forColorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more Institut Bergonié 747
Testing effectiveness (Phase 2)Ended earlyNCT04300140What this trial is testingSafety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Aravive, Inc. 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277972What this trial is testingIparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic TherapyWho this might be right forRCC, Renal Cell Cancer Tianjin Medical University Cancer Institute and Hospital 36
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT00131651What this trial is testingATN-161 in Advanced Renal Cell CancerWho this might be right forCarcinoma, Renal Cell Attenuon 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06245915What this trial is testingAB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)Who this might be right forAdvanced/Metastatic Clear Cell Renal Cell CarcinomaRecurrence Arsenal Biosciences, Inc. 37
Early research (Phase 1)UnknownNCT06049030What this trial is testingHS-10516 in Patients With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Jiangsu Hansoh Pharmaceutical Co., Ltd. 190
Early research (Phase 1)Looking for participantsNCT05433142What this trial is testingStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Xencor, Inc. 307
Early research (Phase 1)Looking for participantsNCT07300241What this trial is testingOpen-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more Neomorph, Inc 30